| Trial ID: | L6667 |
| Source ID: | NCT00171561
|
| Associated Drug: |
Valsartan/Hydrochlorothiazide
|
| Title: |
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension
|
| Interventions: |
DRUG: valsartan/hydrochlorothiazide
|
| Outcome Measures: |
Primary: Blood measures of hypertension after 24 weeks | Secondary: Blood measures of hypertension in arterial system after 24 weeks|Change in protein excretion rate after 24 weeks|Change in serum markers of endothelial function and oxidative stress after 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novartis
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
144
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-03
|
| Completion Date: |
2006-09
|
| Results First Posted: |
|
| Last Update Posted: |
2011-11-08
|
| Locations: |
Novartis Pharmaceuticals, Basel, Switzerland
|
| URL: |
https://clinicaltrials.gov/show/NCT00171561
|
